4.5 Article

Monoclonal Antibody Interactions With Micro- and Nanoparticles: Adsorption, Aggregation, and Accelerated Stress Studies

期刊

JOURNAL OF PHARMACEUTICAL SCIENCES
卷 98, 期 9, 页码 3218-3238

出版社

ELSEVIER SCIENCE INC
DOI: 10.1002/jps.21768

关键词

protein aggregation; adsorption; microparticles; surface chemistry; stability; processing; biotechnology; fluorescence spectroscopy; monolayer; monoclonal antibody

资金

  1. Graduate Assistantship in Areas of National Need (GAANN) program
  2. NIH Leadership in Pharmaceutical Biotechnology program [T32 GM008732]
  3. NIH [1 R01 EB006006-01]
  4. Amgen, Inc

向作者/读者索取更多资源

Therapeutic proteins are exposed to various wetted surfaces that could shed subvisible particles. In this work we measured the adsorption of a monoclonal antibody (mAb) to various microparticles, characterized the adsorbed mAb secondary structure, and determined the reversibility of adsorption. We also developed and used a front-face fluorescence quenching method to determine that the mAb tertiary structure was near-native when adsorbed to glass, cellulose, and silica. Initial adsorption to each of the materials tested was rapid. During incubation studies, exposure to the air-water interface was a significant cause of aggregation but acted independently of the effects of microparticles. Incubations with glass, cellulose, stainless steel, or Fe2O3 microparticles gave very different results. Cellulose preferentially adsorbed aggregates from solution. Glass and Fe2O3 adsorbed the mAb but did not cause aggregation. Adsorption to stainless steel microparticles was irreversible, and caused appearance of soluble aggregates upon incubation. The secondary structure of mAb adsorbed to glass and cellulose was near-native. We suggest that the protocol described in this work could be a useful preformulation stress screening tool to determine the sensitivity of a therapeutic protein to exposure to common surfaces encountered during processing and storage. (c) 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:3218-3238, 2009

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据